Lombard Medical Technologies (LSE:LMT) Asset Impairment Charge : £0.00 Mil (TTM As of Dec. 2012)

View and export this data going back to . Start your Free Trial

What is Lombard Medical Technologies Asset Impairment Charge?

Lombard Medical Technologies's Asset Impairment Charge for the six months ended in Dec. 2012 was £0.00 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Dec. 2012 was £0.00 Mil.

Lombard Medical Technologies Asset Impairment Charge Historical Data

The historical data trend for Lombard Medical Technologies's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lombard Medical Technologies Asset Impairment Charge Chart

Lombard Medical Technologies Annual Data

Trend

Sep02

Dec04

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Asset Impairment Charge

Get a 7-Day Free Trial

Lombard Medical Technologies Semi-Annual Data
	Sep02	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12
Asset Impairment Charge	Get a 7-Day Free Trial					-	-	-	-	-

Lombard Medical Technologies Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Asset Impairment Charge for the trailing twelve months (TTM) ended in Dec. 2012 was £0.00 Mil.

Lombard Medical Technologies Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Lombard Medical Technologies's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

Lombard Medical Technologies (LSE:LMT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lombard Medical Technologies PLC (LSE:LMT) » Definitions » Asset Impairment Charge

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.lombardmedical.com

Lombard Medical Technologies PLC is engaged in the design and development of endovascular stent grafts, their manufacture, and commercialization either directly through the group's own sales force or through a network of local distributors supported by clinical specialists from Lombard Medical. The principal product, the AorfixT AAA stent graft has European CE mark approval for use in patients with high-angle-neck aneurysms of up to 90 degrees. The group has operations in United Kingdom and United States of America.